Клиномир в тестовом запуске. Кто с нами с первых дней, получит отметку «С первых дней» в профиле и первым увидит новые возможности сайта.

Зарегистрироваться
Каталог · ЕАЭС

Клинические исследования и проекты

Solvay Pharmaceuticals · найдено 14

Solvay Pharmaceuticals
Ищем по всем вариантам написания в реестрах, по-русски и по-английски. Спонсор или разработчик.
Статус
Что исследуют
Источник
Фаза
Страна
Участники
Кто может участвовать По критериям ClinicalTrials.gov. Исследования, где реестр возраст и пол не указывает, тоже показываются. Возраст и пол нигде не сохраняются.
Сбросить
14 исследований
Завершено Фаза III Россия
continuous combined estradiol and dydrogesterone; continuous combined estradiol and dydrogesterone; Placebo · Solvay Pharmaceuticals

A Randomized, Placebo-Controlled, Double-Blind, Multi-National Study to Demonstrate Efficacy of Continuous Combined 0.5 mg Estradiol and 2.5 mg Dydrogesterone in the Treatment of Vasomotor Symptoms in Postmenopausal Women in Comparison to Placebo Over 3 Months, and to Investigate the Bleeding Pattern Over a Double-Blind Treatment Period of One Year Compared With Continuous Combined 1 mg Estradiol and 5 mg Dydrogesterone

391 участник во всех странах ClinicalTrials.gov S102.3.119
Завершено Фаза III Россия
Tedisamil sesquifumarate · Solvay Pharmaceuticals

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety of Intravenous Tedisamil Sesquifumarate in the Rapid Conversion to Normal Sinus Rhythm in Female Subjects With Recent Onset Atrial Fibrillation

ClinicalTrials.gov S219.3.116
Прекращено Здоровые добровольцы Россия
SLV320 · Solvay Pharmaceuticals

Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Sequential Cohort Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

300 участников во всех странах ClinicalTrials.gov S320.2.003
Прекращено Фаза II Россия
SLV320; SLV320; SLV320; SLV320; Placebo · Solvay Pharmaceuticals

A Double-Blind, Placebo-Controlled, Randomized, Multi-Center, Dose-Finding Study of SLV320, a Selective A1 Adenosine Receptor Antagonist, to Evaluate the Effect on Renal Function and Safety in Subjects Hospitalized With Acute Decompensated Heart Failure and Renal Dysfunction (Reno-Defend 1)

Москва, Санкт-Петербург и ещё 4 города 16 центров 46 участников во всех странах ClinicalTrials.gov S320.2.011
Завершено Фаза III Россия
Levodopa (Pardoprunox); Placebo Comparator · Solvay Pharmaceuticals

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of SLV308 as Adjunct Therapy to Levodopa in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

295 участников во всех странах ClinicalTrials.gov S308.3.002
Завершено Фаза III Россия
Fenofibrate/Simvastatin; Fenofibrate/Simvastatin; Pravastatin · Solvay Pharmaceuticals

A Multicenter, Double-Blind, Randomized, Forced-Titration Study to Compare the Efficacy and Safety of the Combination of 145 mg Fenofibrate and 20 or 40 mg Simvastatin With 40 mg Pravastatin Monotherapy in Patients With Mixed Dyslipidemia at Risk of Cardiovascular Disease Not Adequately Controlled by 40 mg Pravastatin Alone

423 участника во всех странах ClinicalTrials.gov C LF0242780-01 05 04
Завершено Фаза III Россия
Pardoprunox · Solvay Pharmaceuticals

An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients

224 участника во всех странах ClinicalTrials.gov S308.3.006
Завершено Фаза III Россия
Pardoprunox · Solvay Pharmaceuticals

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Москва, Санкт-Петербург и ещё 2 города 9 центров 140 участников во всех странах ClinicalTrials.gov S308.3.007
Прекращено Фаза II Россия
Placebo; Recombinant Microbial Lipase SLV339; Recombinant Microbial Lipase SLV339; Recombinant Microbial Lipase SLV339 · Solvay Pharmaceuticals

A Multi-center, Single-blind, Parallel-design, Randomized, Placebo-controlled, Dose-ranging Study to Evaluate Oral Recombinant Microbial Lipase Efficacy in Patients With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

56 участников во всех странах ClinicalTrials.gov S339.2.001
Завершено Фаза II Россия
1 251 участник во всех странах ClinicalTrials.gov S030.2.112
Завершено Фаза III Россия
pardoprunox; Pardoprunox; Pardoprunox; Placebo · Solvay Pharmaceuticals

A Randomized, Double Blind, Placebo Controlled Parallel-Group Fixed and Flexible SLV308 Dose Arm Study to Assess Efficacy and Safety of SLV308 Monotherapy in the Treatment of Patients With Early Stage Parkinson's Disease

468 участников во всех странах ClinicalTrials.gov S308.3.001
Завершено Фаза II Россия
Cetrorelix · Solvay Pharmaceuticals

A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis

ClinicalTrials.gov S184.2.101
Завершено Фаза III Россия
Tedisamil sesquifumarate · Solvay Pharmaceuticals

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety of Intravenous Tedisamil Sesquifumarate in the Rapid Conversion to Normal Sinus Rhythm in Male Subjects With Recent Onset Atrial Fibrillation or Flutter

ClinicalTrials.gov S219.3.117

Изменения не сохранены

На этой странице есть несохранённые изменения. Если уйти со страницы, они пропадут.